Celsion Corporation (NASDAQ:CLSN)

CAPS Rating: 1 out of 5

A biotechnology company dedicated to furthering the development and commercialization of treatment systems for cancer and other diseases using focused heat energy in combination with other therapeutic devices or heat-activated genes.


Player Avatar SkepBioInvestor (95.83) Submitted: 10/9/2012 4:24:17 PM : Underperform Start Price: $23.72 CLSN Score: +82.18

over-hyped stock, no Wall St. interest (according to Adam F.) a co. employee has a blog and a twitter account devoted exclusively to pumping the stock. Negative HEAT data.

Featured Broker Partners